Delays in the diagnosis and treatment of tuberculous lymphadenitis in low-incidence countries: A systematic review
Respiration Apr 21, 2019
Mathiasen VD, et al. - Researchers analyzed 11 heterogeneous studies, identified from PubMed, to assess patient delay, health care delay, and total delay (ie, time to first health care contact, diagnosis, and treatment) in patients with tuberculous lymphadenitis (TBLA) in tuberculosis (TB) low-incidence countries. The included studies addressed health care seeking behaviour, patient delay, health care delay, and/or total delay in TB low-incidence countries (defined as <20 per 100,000 citizens). They found variation from 55 to 154 days (range, 14–1,461) for mean patient delay, from 44 to 94 days (range, 7–224) for mean health care delay and from 77.5 to 122 days (range, 0–2,820) for median total delay. It is justifiable to gain comprehensive insights into the diagnostic pathway and delay in TBLA patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries